Notice Number: NOT-NS-14-017

Key Dates
Release Date: March 4, 2014

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

On January 16, 2014 the National Institute of Neurological Disorders and Stroke (NINDS) issued a Notice (NOT-NS-14-008) informing applicants that the CFDA number for PAR-13-278 "NINDS Phase III Investigator-Initiated Efficacy Clinical Trials (U01)" should be 93.853. Unfortunately, the application packages available in Grants.gov still reflected the old CFDA number. Although it is standard practice for NIH staff to verify and correct CFDA numbers after submission, some applicants have raised concerns regarding the display of the incorrect CFDA in their applications.

To address these concerns, we have posted a new application package in Grants.gov identified by a Competition ID of ‘FORMS-C-REVISED’ and a Competition Title of ‘Includes CFDA correction must be used for due dates on or after May 8, 2014'.

If you have already started to prepare your application for the March 5, 2014 due date for renewal, resubmission or revision applications or the May 7, 2014 due date for AIDS and AIDS-Related applications, then you have two options:

1. Submit using the old application package. Although the application image in eRA Commons will show the old CFDA, NIH staff will adjust the CFDA number in our system and process your application correctly.
2. Revisit PAR-13-278, download the new application package, and transfer your application data for submission.

After the May 7, 2014 AIDS due date, the old application package will be closed and application submissions using the old package will no longer be accepted.

Inquiries

Please direct all inquiries to:

Wendy Galpern, MD, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9135
Email: [email protected]